BPC-157 10mg

BPC-157 (10mg) — Research Compound

BPC-157 (Body Protection Compound 157) is a pentadecapeptide derived from a protective protein found in human gastric juice. It is studied for its wide-ranging cytoprotective effects, particularly within the gastrointestinal tract and the musculoskeletal system. Research focuses on its ability to modulate the nitric oxide (NO) pathway and interact with growth factor expression to accelerate the healing of diverse tissues, including bone, muscle, and tendons.

Findings from early-stage clinical trials have reported:

• Marked acceleration in the healing of transected tendons and ligaments observed in experimental models
  
• Protective effects on the gastric mucosa and the reversal of NSAID-induced damage reported in-vitro
  
• Enhanced rates of angiogenesis and increased expression of vascular endothelial growth factor (VEGF) noted
  
• Observed improvements in the recovery of the “brain-gut” axis following systemic stress reported in-vivo
  

Researchers study BPC-157 to investigate its potential as a broad-spectrum regenerative agent. Its ability to remain stable in gastric juice makes it a unique model for studying localized versus systemic peptide activity. This compound is a primary focus for research into inflammatory bowel disease, complex soft tissue repair, and the biological mechanisms of organoprotection.

Available Formats:
This compound is available as a vial of lyophilised powder, or can be ordered in a disposable pen, a reusable pen, or a cartridge for an existing reusable pen system.

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment or investigation
• Supplied to another party for human investigational use